Detection of microRNA expression levels based on microarray analysis for classification of idiopathic pulmonary fibrosis

被引:7
|
作者
Li, Qilong [1 ]
Li, Mohan [2 ]
Zheng, Kexin [2 ]
Li, Hong [3 ]
Yang, Hong [4 ]
Ma, Shiliang [1 ]
Zhong, Ming [1 ]
机构
[1] Shenyang Agr Univ, Coll Biosci & Biotechnol, 120 Dongling Rd, Shenyang 110866, Liaoning, Peoples R China
[2] Shenyang Agr Univ, Coll Food Sci, Shenyang 110866, Liaoning, Peoples R China
[3] Fushun Cent Hosp, Dept Pharm, Fushun 113006, Liaoning, Peoples R China
[4] Shenyang Thorac Hosp, Dept Pathol, Shenyang 110044, Liaoning, Peoples R China
关键词
idiopathic pulmonary fibrosis; biomarker; support vector machine-recursive feature elimination; microRNA; bioinformatics; FIBROBLAST PROLIFERATION; MECHANISMS; TIME;
D O I
10.3892/etm.2020.9068
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The etiology and pathophysiological mechanisms of idiopathic pulmonary fibrosis (IPF) are yet to be fully elucidated; however, mining of disease-related microRNAs (miRNAs/miRs) has improved the understanding of the progression of IPF. The aim of the current study was to screen miRNAs associated with IPF using three mathematical algorithms: One-way ANOVA, least absolute shrinkage and selector operation (LASSO) and support vector machine-recursive feature elimination (SVM-RFE). Using ANOVA, three miRNAs and two miRNAs were selected with opposite expression patterns in moderate and severe IPF, respectively. In total, two algorithms, LASSO and SVM-RFE, were used to perform feature selection of miRNAs. miRNAs from patients were also extracted from formalin-fixed paraffin-embedded tissues and detected using reverse transcription-quantitative PCR (RT-qPCR). The intersection of the three algorithms (ANOVA, LASSO and SVM-RFE) was taken as the final result of the miRNA candidates. Three miRNA candidates, including miR-124, hsa-miR-524-5p and hsa-miR-194 were therefore used as biomarkers. The receiver operating characteristic model demonstrated favorable discrimination between IPF and control groups, with an area under the curve of 78.5%. Moreover, RT-qPCR results indicated that miR-124, hsa-miR-524-5p, hsa-miR-194 and hsa-miR-133a were differentially expressed between patients with IPF and age-matched men without fibrotic lung disease. The target genes of these miRNAs were further predicted and Kyoto Encyclopedia of Genes and Genomes enrichment analysis was performed. Collectively, the present results suggested that the identified miRNAs associated with IPF may be useful biomarkers for the diagnosis of this disease.
引用
收藏
页码:3096 / 3103
页数:8
相关论文
共 50 条
  • [31] MicroRNA and protein-coding gene expression analysis in idiopathic pulmonary fibrosis yields novel biomarker signatures associated to survival
    Casanova, Nancy G.
    Zhou, Tong
    Gonzalez-Garay, Manuel L.
    Lussier, Yves A.
    Sweiss, Nadera
    Ma, Shwu-Fan
    Noth, Imre
    Knox, Kenneth S.
    Garcia, Joe G. N.
    [J]. TRANSLATIONAL RESEARCH, 2021, 228 : 1 - 12
  • [32] Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry
    Jo, Helen E.
    Glaspole, Ian
    Grainge, Christopher
    Goh, Nicole
    Hopkins, Peter M. A.
    Moodley, Yuben
    Reynolds, Paul N.
    Chapman, Sally
    Walters, E. Haydn
    Zappala, Christopher
    Allan, Heather
    Keir, Gregory J.
    Hayen, Andrew
    Cooper, Wendy A.
    Mahar, Annabelle M.
    Ellis, Samantha
    Macansh, Sacha
    Corte, Tamera J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (02)
  • [33] Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis
    Patel, Nina M.
    Kawut, Steven M.
    Jelic, Sanja
    Arcasoy, Selim M.
    Lederer, David J.
    Borczuk, Alain C.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (06) : 1324 - 1330
  • [34] Lactate Levels in Airways of Patients with Cystic Fibrosis and Idiopathic Pulmonary Fibrosis
    Worlitzsch, Dieter
    Meyer, Keith C.
    Doering, Gerd
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (01) : 111 - 111
  • [35] Cytokine levels in the sera of patients with idiopathic pulmonary fibrosis
    Tsoutsou, PG
    Gourgoulianis, KI
    Petinaki, E
    Germenis, A
    Tsoutsou, AG
    Mpaka, M
    Efremidou, S
    Molyvdas, PA
    [J]. RESPIRATORY MEDICINE, 2006, 100 (05) : 938 - 945
  • [36] Integration of Genome-Wide MicroRNA and mRNA Expression Profiles in Pulmonary Arterial Hypertension and Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis
    Rajkumar, Revathi
    Shariff, Afreen I.
    Choi, Ji-in
    Huang, Grace T.
    Pandit, Kusum V.
    Sembrat, John C.
    Ishizawar, David C.
    Richards, Thomas J.
    Benos, Panayiotis V.
    Kaminski, Naftali
    Ahmad, Ferhaan
    [J]. CIRCULATION, 2011, 124 (21)
  • [37] Comparative Analysis of Gene Expression in Fibroblastic Foci in Patients with Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis
    Kamp, Jan C.
    Neubert, Lavinia
    Stark, Helge
    Hinrichs, Jan B.
    Boekhoff, Caja
    Seidel, Allison D.
    Ius, Fabio
    Haverich, Axel
    Gottlieb, Jens
    Welte, Tobias
    Braubach, Peter
    Laenger, Florian
    Hoeper, Marius M.
    Kuehnel, Mark P.
    Jonigk, Danny D.
    [J]. CELLS, 2022, 11 (04)
  • [38] AN INTEGRATED MICRORNA AND MRNA INTERPLAY REVEALS THE PATHOGENESIS OF IDIOPATHIC PULMONARY FIBROSIS
    Wang, L.
    Zhao, H.
    Zhang, L.
    Chen, Q.
    [J]. RESPIROLOGY, 2016, 21 : 198 - 198
  • [39] MicroRNA-21 as a potential therapeutic target in idiopathic pulmonary fibrosis
    Vaccarello, P.
    Ramanujam, D. P.
    Schiller, H.
    Staab-Weijnitz, C.
    Engelhardt, S.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (SUPPL 1) : S39 - S39
  • [40] Prevalence of idiopathic pulmonary fibrosis in Japan based on a claims database analysis
    Yasuhiro Kondoh
    Takafumi Suda
    Yoshie Hongo
    Manami Yoshida
    Shinzo Hiroi
    Kosuke Iwasaki
    Tomomi Takeshima
    Sakae Homma
    [J]. Respiratory Research, 23